📍Check this published paper in #PathogensMDPI 2023!
🔬A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria by Parvinder Kaur et al.
🔗Read more here: https://www.mdpi.com/2076-0817/13/1/40
@pathogensmdpi.bsky.social
@pathogensmdpi.bsky.social📍Check this published paper in #PathogensMDPI 2023!
🔬A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria by Parvinder Kaur et al.
🔗Read more here: https://www.mdpi.com/2076-0817/13/1/40
@dctomaz.bsky.socialNow this is a beautiful use of CRISPR. 🧬 15 mycobacterial species distinguished in 3.5 hours — no painfully long culture times. Translational science doing its job. 🔬 #CRISPR #Microbiology #Diagnostics #Mycobacteria #Biotechnology #TranslationalScience #Science
@science.orgA CRISPR-based, nanodroplet test can distinguish 15 species of nontuberculous #mycobacteria in clinical samples in just 3.5 hours, avoiding the need for long culture times that have long limited assays for mycobacteria. #ScienceTranslationalMedicine https://scim.ag/4iGFeEF
@biominnie.bsky.social🦠Thrilled our paper on #NTM in First Nations People in Australia was accepted in @bmc.springernature.com www.doi.org/10.1186/s128... but the early access has been missing all tables/figures for 5 weeks. Help?! 😅
#mycobacteria